Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ethyl 19-amino-15-(2-amino-2-oxoethyl)-12-(4-aminobutyl)-3-(2-(1-(2-(1-(2-(2-(5-(5-(4-bromophenyl)thiophen-2-yl)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)-N-methylacetamido)acetyl)-2-(phenylcarbamoyl)hydrazinyl)acetyl)-2-(4-methoxybenzoyl)hydrazinyl)acetyl)-9-(2-methoxyethyl)-6-(4-nitrobenzamido)-5,8,11,14-tetraoxo-2,3,6,9,12,15-hexaazanonadecan-1-oate
ID: ALA3827129
Chembl Id: CHEMBL3827129
PubChem CID: 127045261
Max Phase: Preclinical
Molecular Formula: C67H82BrN19O20S
Molecular Weight: 1585.48
Molecule Type: Small molecule
Associated Items: